Dr Frank F. Craig (CEO) will be attending Analytica 2014. The conference is being held in Munich, Germany on April 1st – 4th. “Analytica has over 1,000 exhibitors and circa 30,000 trade visitors. We are attending to ensure that we are updated with new innovations in industry and also to meet with new potential customers and collaborators. Analytica is the biggest conference of its type in Europe, so Sphere Fluidics aims to be there to help promote our single cell analysis technology.” For conference information, see here.
Dr Marian Rehak (R&D Director) will be speaking at the upcoming SynBioBeta Conference in London on 3rd April, 2014. He stated “I will be speaking on novel applications of picodroplets for single cell analysis in Synthetic Biology. The conference brings together excellent international scientists and minds in this exciting, emerging area.” Conference information can be found here.
Sphere Fluidics has been profiled in the March edition of Nature Biopharma Dealmakers. The article was entitled “Using picodroplets to find the next blockbuster” and was authored by Dr Rob Marchmont (Commercial Director of Sphere Fluidics). The article discusses company commercial and technical progress over the last year and the ability of picodroplets to perform upto one billion assays per biochip per day. More information can be found here.